![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 19, 14077-14083, May 12, 2000
From the A growing number of reports suggest that elevated
levels of extracellular Alzheimer's
Alzheimer's
-Amyloid, Human Islet Amylin, and Prion Protein
Fragment Evoke Intracellular Free Calcium Elevations by a Common
Mechanism in a Hypothalamic GnRH Neuronal Cell Line*
,
,
Department of Molecular and Cellular
Neurobiology, Tokyo Metropolitan Institute for Neuroscience, 2-6 Musashidai, Fuchu, Tokyo 183-8526, Japan, the § Department
of Anatomy and Cell Biology, Uniformed Services University of Health
Sciences, Bethesda, Maryland 20892, and the ¶ Institute of
Biomedical Sciences, Faculty of Medicine, University of Chile,
Independencia 1027 Santiago, Chile
-amyloid protein alter the
homeostasis of free [Ca2+]i in different
cell types of the mammalian brain. In line with these results, we have
previously shown that A
P[1-40] forms cation-selective channels
(Ca2+ included) across artificial planar bilayers formed
from acidic phospholipids and across excised membrane patches from
immortalized hypothalamic GnRH neurons (GT1-7 cells), suggesting that
the nonregulated Ca2+-influx through these spontaneously
formed "amyloid channels" may provide a mechanism to explain its
toxicity (1). We have now found and report here that the application of
A
P[1-40] to GT1-7 neurons consistently elevates
[Ca2+]i levels. We also found that human islet
amylin and the prion protein fragment (PrP106-126), peptides that
acquire
-pleated sheet conformation in water solutions and have been reported to form ion channels across planar bilayer membranes, also
increase cytosolic free calcium in GT1-7 neurons. Searching for
protective agents, we found that soluble cholesterol, known to decrease
the fluidity of the cell membrane, inhibits A
P[1-40]-evoked [Ca2+]i rise. These results suggest that
unregulated Ca2+ entry across amyloid channels may be a
common mechanism causing cell death, not only in diseases of the third
age, including Alzheimer's disease and type 2 diabetes mellitus, but
also in prion-induced diseases.
*
This work was supported in part by funds from the Japan
Health Sciences Foundation (to M. K. and Y. K.), Fondo
Nacíonal de Ciencia y Tecnologia Grant 1950774, and the 1996 Chilean Presidential Cathedra (to E. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Faculty of
Medicine, University of Chile, Casilla 70005, Correo 7, Santiago,
Chile. Fax: 56-2-7776886; E-mail: erojas@machi.med.uchile.cl.
This article has been cited by other articles:
![]() |
G. Valincius, F. Heinrich, R. Budvytyte, D. J. Vanderah, D. J. McGillivray, Y. Sokolov, J. E. Hall, and M. Losche Soluble Amyloid {beta}-Oligomers Affect Dielectric Membrane Properties by Bilayer Insertion and Domain Formation: Implications for Cell Toxicity Biophys. J., November 15, 2008; 95(10): 4845 - 4861. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Arispe, J. C. Diaz, and M. Flora Efficiency of Histidine-Associating Compounds for Blocking the Alzheimer's A{beta} Channel Activity and Cytotoxicity Biophys. J., November 15, 2008; 95(10): 4879 - 4889. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Hartley, C. Zhao, A. C. Speier, G. A. Woodard, S. Li, Z. Li, and T. Walz Transglutaminase Induces Protofibril-like Amyloid {beta}-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation J. Biol. Chem., June 13, 2008; 283(24): 16790 - 16800. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Haataja, T. Gurlo, C. J. Huang, and P. C. Butler Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis Endocr. Rev., May 1, 2008; 29(3): 303 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefani Generic Cell Dysfunction in Neurodegenerative Disorders: Role of Surfaces in Early Protein Misfolding, Aggregation, and Aggregate Cytotoxicity Neuroscientist, October 1, 2007; 13(5): 519 - 531. [Abstract] [PDF] |
||||
![]() |
G. E. Stutzmann The Pathogenesis of Alzheimers Disease Is It a Lifelong "Calciumopathy"? Neuroscientist, October 1, 2007; 13(5): 546 - 559. [Abstract] [PDF] |
||||
![]() |
K. M. Danzer, D. Haasen, A. R. Karow, S. Moussaud, M. Habeck, A. Giese, H. Kretzschmar, B. Hengerer, and M. Kostka Different Species of {alpha}-Synuclein Oligomers Induce Calcium Influx and Seeding J. Neurosci., August 22, 2007; 27(34): 9220 - 9232. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Priller, T. Bauer, G. Mitteregger, B. Krebs, H. A. Kretzschmar, and J. Herms Synapse formation and function is modulated by the amyloid precursor protein. J. Neurosci., July 5, 2006; 26(27): 7212 - 7221. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pieri, M. Bucciantini, D. Nosi, L. Formigli, J. Savistchenko, R. Melki, and M. Stefani The Yeast Prion Ure2p Native-like Assemblies Are Toxic to Mammalian Cells Regardless of Their Aggregation State J. Biol. Chem., June 2, 2006; 281(22): 15337 - 15344. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Lashuel Membrane Permeabilization: A Common Mechanism in Protein-Misfolding Diseases Sci. Aging Knowl. Environ., September 21, 2005; 2005(38): pe28 - pe28. [Abstract] [Full Text] |
||||
![]() |
C. Cecchi, S. Baglioni, C. Fiorillo, A. Pensalfini, G. Liguri, D. Nosi, S. Rigacci, M. Bucciantini, and M. Stefani Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates J. Cell Sci., August 1, 2005; 118(15): 3459 - 3470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quist, I. Doudevski, H. Lin, R. Azimova, D. Ng, B. Frangione, B. Kagan, J. Ghiso, and R. Lal Amyloid ion channels: A common structural link for protein-misfolding disease PNAS, July 26, 2005; 102(30): 10427 - 10432. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Demuro, E. Mina, R. Kayed, S. C. Milton, I. Parker, and C. G. Glabe Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers J. Biol. Chem., April 29, 2005; 280(17): 17294 - 17300. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Ciccotosto, D. Tew, C. C. Curtain, D. Smith, D. Carrington, C. L. Masters, A. I. Bush, R. A. Cherny, R. Cappai, and K. J. Barnham Enhanced Toxicity and Cellular Binding of a Modified Amyloid {beta} Peptide with a Methionine to Valine Substitution J. Biol. Chem., October 8, 2004; 279(41): 42528 - 42534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bucciantini, G. Calloni, F. Chiti, L. Formigli, D. Nosi, C. M. Dobson, and M. Stefani Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity J. Biol. Chem., July 23, 2004; 279(30): 31374 - 31382. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Suen, M.-S. Yu, K.-F. So, R. C.-C. Chang, and J. Hugon Upstream Signaling Pathways Leading to the Activation of Double-stranded RNA-dependent Serine/Threonine Protein Kinase in {beta}-Amyloid Peptide Neurotoxicity J. Biol. Chem., December 12, 2003; 278(50): 49819 - 49827. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bahadi, P. V. Farrelly, B. L. Kenna, J. I. Kourie, F. Tagliavini, G. Forloni, and M. Salmona Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients Am J Physiol Cell Physiol, October 1, 2003; 285(4): C862 - C872. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bahadi, P. V. Farrelly, B. L. Kenna, C. C. Curtain, C. L. Masters, R. Cappai, K. J. Barnham, and J. I. Kourie Cu2+-induced modification of the kinetics of A{beta}(1-42) channels Am J Physiol Cell Physiol, October 1, 2003; 285(4): C873 - C880. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Heller, K. F. Winklhofer, J. Heske, A. Reintjes, and J. Tatzelt Post-translational Import of the Prion Protein into the Endoplasmic Reticulum Interferes with Cell Viability: A CRITICAL ROLE FOR THE PUTATIVE TRANSMEMBRANE DOMAIN J. Biol. Chem., September 19, 2003; 278(38): 36139 - 36147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Michaelis Drugs Targeting Alzheimer's Disease: Some Things Old and Some Things New J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. ARISPE and M. DOH Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease A{beta}P (1-40) and (1-42) peptides FASEB J, October 1, 2002; 16(12): 1526 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Taylor, K. N. Green, I. F. Smith, and C. Peers Prion protein fragment 106-126 potentiates catecholamine secretion from PC-12 cells Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1850 - C1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. O'Donovan, D. Tobin, and T. G. Cotter Prion Protein Fragment PrP-(106-126) Induces Apoptosis via Mitochondrial Disruption in Human Neuronal SH-SY5Y Cells J. Biol. Chem., November 16, 2001; 276(47): 43516 - 43523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferraretto, A. Signorile, C. Gravaghi, A. Fiorilli, and G. Tettamanti Casein Phosphopeptides Influence Calcium Uptake by Cultured Human Intestinal HT-29 Tumor Cells J. Nutr., June 1, 2001; 131(6): 1655 - 1661. [Abstract] [Full Text] |
||||
![]() |
M. Ettaiche, R. Pichot, J.-P. Vincent, and J. Chabry In Vivo Cytotoxicity of the Prion Protein Fragment 106-126 J. Biol. Chem., November 17, 2000; 275(47): 36487 - 36490. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Curtain, F. Ali, I. Volitakis, R. A. Cherny, R. S. Norton, K. Beyreuther, C. J. Barrow, C. L. Masters, A. I. Bush, and K. J. Barnham Alzheimer's Disease Amyloid-beta Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits J. Biol. Chem., June 1, 2001; 276(23): 20466 - 20473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |